In a report released yesterday, Gregory Renza from RBC Capital maintained a Buy rating on Cormedix (CRMD – Research Report), with a price ...

UBS Group AG has hired three investment bankers specializing in biotechnology from RBC Capital Markets as the bank looks to expand its health-care dealmaking in the US.Noël Brown will become head of ...

$70,000 of RBC CAPITAL MARKETS LLC (FORMERLY REGISTERED AS ROYAL BANK OF CANADA) lobbying was just disclosed, from Q3 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on ...

Three is a trend, as RBC Capital Markets joined Goldman Sachs and Yardeni Research in slashing S&P 500 price targets. RBC lowered its year-end view on the main U.S. stock market index SPX to 6,200 ...

On Monday, RBC Capital Markets reiterated their positive stance ... to acquire Applications Software (ETR:SOWGn) Technology LLC, an Oracle (NYSE:ORCL) consultancy firm. This acquisition is ...

Cambridge, UK, 14 March 2025 - 4basebio PLC (AIM: 4BB), an innovation-led provider of novel synthetic DNA products and a non-viral, thermostable nucleic acid delivery platform, announces that RBC ...

CLEVELAND, Feb. 25, 2025 /PRNewswire/ -- KeyCorp (NYSE: KEY) announced today that Clark Khayat, Chief Financial Officer, will speak at the 2025 RBC Capital Markets Global Financial Institutions ...

And this is part of that offensive play, where we really ramped up our capabilities in the capital markets and global trade type of set of businesses. This global transaction services is not ...

is scheduled to present at the 2025 RBC Capital Markets Global Financial Institutions Conference being held on March 4, 2025. Mr. Greenberg will participate in a panel titled "The Outlook in ...